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Background: Poor sleep quality, a novel risk factor of cardiovascular diseases (CVD), is highly prevalent in patients
with chronic kidney disease (CKD). The association between poor sleep quality and cardiovascular damage in
patients with CKD is unclear. This study is aimed to assess the prevalence and related risk factors of sleep
disturbance and determine the relationship between sleep quality and cardiovascular damage in Chinese patients
with pre-dialysis CKD.
Methods: A total of 427 pre-dialysis CKD patients (mean age = 39 ± 15 years, 260 male/167 female) were recruited
in this study. The demographics and clinical correlates were collected. The sleep quality was measured by the
Pittsburgh Sleep Quality Index (PSQI), whereas the cardiovascular damage indicators (the Early/late diastolic
peak flow velocity (E/A) ratio and left ventricular mass index (LVMI)) were determined by an echocardiographic
examination.
Results: Of the CKD patients, 77.8% were poor sleepers as defined by a PSQI score > 5. Median estimated
glomerular filtration rate (eGFR) was 69.4(15.8-110.9) ml/min/1.73 m2. Logistic regression analysis revealed that left
ventricular hypertrophy (LVH) was independently associated with the PSQI score (OR = 1.092, 95% CI = 1.011-1.179,
p = 0.025), after adjustment for age, sex and clinical systolic blood pressure, diastolic blood pressure, Phosphate,
Intact parathyroid hormone (iPTH), Hemoglobin and eGFR. The linear regression analysis showed that the E/A ratios
were independently associated with the PSQI score (β = −0.115, P = 0.028) after adjustment for a series of potential
confounding factors.
Conclusions: Poor sleep quality, which is commonly found in pre-dialysis CKD patients, is an independent factor
associated with cardiovascular damage in CKD patients. Our finding implies that the association between poor sleep
and CVD might be mediated by cardiac remodeling.
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Sleep-related problems and disorders are common pro-
blems in end-stage renal disease (ESRD) patients [1].
Several studies have shown that the prevalence of sleep
problems including sleep apnea, insomnia, periodic limb
movement disorder (PLMD), restless leg syndrome and
overall poor sleep quality ranges from 30 to 80% among
these patients [1,2]. There is substantial evidence indicat-
ing that insufficient sleep and poor sleep quality promote
the development and exacerbate the severity of three
important risk factors for chronic kidney disease (CKD),
namely, type 2 diabetes, hypertension and obesity [3].
Poor sleep quality has been associated with an increased
risk of mortality in pre-ESRD patients [4]. Recent studies
have shown that poor sleep quality was related to the pro-
gression of cardiovascular disease (CVD) [5,6]. CVD is the
most common cause of death in CKD patients in almost
all stages. A previous study found that poor sleep quality
was associated with a higher rate of CVD in continuous
ambulatory peritoneal dialysis (CAPD) patients [7]. The
pathophysiological pathways between poor sleep patterns
and CVD remain unclear. Relatively few studies have ex-
amined sleep problems in the considerably larger group of
patients with pre-dialysis CKD, and the related factors of
poor sleep quality are not clear in these populations. Re-
cent studies reported that the prevalence of poor sleep in
CKD (prior to ESRD) varies widely from 14% to as high as
85% [3]. The association between sleep quality and specific
laboratory variables was inconsistent in these studies.
Kurella et al. reported a significant association between
eGFR and sleep quality [8], whereas other studies failed to
show a relationship between renal function and sleep
quality [4,9]. Further research with a larger sample size
and a different study population is needed.
There is no sleep quality data on Chinese pre-dialysis
CKD patients. In this study, we aimed to assess the
prevalence and associated risk factors of self-reported
poor sleep quality and whether self-reported poor sleep
quality is associated with biomarkers of cardiovascular
damage (LVH and E/A ratio) disease in Chinese CKD
patients.
Methods
The study protocol was approved by the Ethics Committee
of the 3rd hospital of Sun Yat-Sen University, and all of the
study participants provided written informed consent be-
fore enrolling in this study.
Patients
The patients were recruited from May 2009 to Dec 2012.
The CKD patients were diagnosed using the clinical
practice guidelines set by the National Kidney Foundation
Disease Outcomes Quality Initiative (NKF-K/DOQI) [10].
The inclusion criteria were as follows: 1) Pre-dialysis CKDpatients with a stable disease state; 2) respondent to the
sleep questionnaire and able to read and write and with-
out a communication barrier. The exclusion criteria were
as follows: 1) age <18 years; 2) treatment with corticoste-
roids or hormones; 3) acute changes in the estimated
glomerular filtration rate (eGFR) >30% in the previous
3 months; 4) pregnancy; 5) a history of abuse of drugs or
alcohol; 6) night or shift work employment; 7) diagnosed
sleep apnea and chronic obstructive pulmonary disease;
8) known acquired immunodeficiency syndrome (AIDS)
or active infection; 9) acute cardiovascular disorders
(unstable angina pectoris, heart failure, life-threatening
arrhythmia, atrial fibrillation); 10) renal replacement the-
rapy (hemodialysis, peritoneal dialysis or renal transplant);
Body mass index more than 30 kg/m2.
A total of 498 patients were diagnosed with CKD: 10 pa-
tients were treated with corticosteroids or hormones, 5
patients were < 18 years old, 6 patients had an acute eGFR
decrease, 8 patients had acute cardiovascular disorders, 9
patients had an infection, 12 patients were in renal re-
placement therapy and 3 patients had shift work employ-
ment, and these patients were excluded according to the
exclusion criteria. Remaining patients (n=445) was re-
cruited for the study: 18 patients could not complete the
questionnaire (10 patients could not read and write or had
a communication barrier; 5 patients’ questionnaires were
invalid; and 3 patients refused to complete the question-
naire). Finally, 427 patients completed the questionnaire
and were enrolled in the study.
Measurement
Sleep quality was measured using the Pittsburgh Sleep
Quality Index (PSQI) [11], which contains 19 items. The
PSQI is a self-administered questionnaire to assess a
patient’s sleep quality during the past month. From the
patients’ answers, the 19 questions are grouped into seven
components scores, including subjective sleep quality,
sleep latency, sleep duration, sleep efficiency, sleep dis-
turbance, use of sleep medications, and daytime dysfunc-
tion, were calculated. Each component was scored from 0
to 3 to yield a global PSQI score from 0 to 21. A high
PSQI score indicates poor sleep quality. According to
Buysse et al., patients with a PSQI score > 5 are conven-
tionally defined as “poor sleepers”, whereas those with a
score ≤ 5 are considered “good sleepers”. A previous study
of primary insomniacs and healthy controls in commu-
nity-dwelling adults reported that the cutoff score of 5 in
the Chinese version PSQI has a sensitivity and specificity
of 98% and 55%, respectively [12].
Depression were assessed using the short form of the
Beck Depression Inventory (BDI-SF) [13], a widely used
13-item questionnaire scored on a 4-point scale, from 0
to 3, with overall scores ranging from 0 to 39. Overall
scores of 0–4 indicate no depression, 5–7 indicate mild,
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depression. The BDI-SF has been found to have a good
correlation with the standard 21-item BDI (r = 0.96,
p = 0.001) and relates to the clinical depth-of-depression
(r = 0.61) [13], with similar diagnostic efficiency [14].
We administered the Chinese version of the Beck
Depression Inventory (BDI) to evaluate depression in
the patients [15].
Other data collected
The clinical data recorded included duration of CKD,
gender, age, current tobacco and alcohol intake, height
and weight, blood pressure (BP), 24-h urinary protein ex-
cretion, serum albumin (ALB), serum creatinine (SCR),
Serum uric acid, total cholesterol (TC), triglycerides (TG)
and hemoglobin (HGB). The eGFR was estimated using
the Chinese abbreviated MDRD (Modification of Diet in
Renal Disease) equation [16]. The 24-h urinary protein ex-
cretion was calculated from a 24 h urine collection. The
Scr, TC, ALB and TG concentrations were measured by a
Hitachi 7180 biochemistry autoanalyzer (Hitachi, Tokyo,
Japan; reagents from Roche Diagnostics, Mannheim,
Germany). The Scr levels were measured by enzymatic
and traceable to the isotope dilution mass spectrometry at
the time of the study.
Carotid ultrasonography
Carotid intima-media thickness (cIMT) was assessed by
two trained investigators before study commencement. A
SonoSite MicroMaxx Ultrasound System paired with a
5–10-MHz Multifrequency High-resolution linear trans-
ducer (Bothell, WA, USA) with Sono-Calc IMT software
was used for taking automatic measurements of cIMT.
This was achieved by averaging three measurements taken
on each carotid artery (anterior, lateral and posterior
directions) and measuring the distance between the lea-
ding edge of the lumen–intima interface and the leading
edge of the collagenous upper layer of the adventitia using
high-resolution B-mode ultrasonography.
Cardiac assessment
Two-dimensional echocardiography was used to assess the
volume, mass, systolic function and diastolic function of
the left ventricle. The left ventricular mass was calculated
using the Devereux method [17]. The left ventricular mass
index (LVMI) was obtained by calculating the left ventri-
cular mass to the height2.7 [18]. The males with a LVMI
of >49 g/m2.7 and the females with a LVMI of > 45 g/m2.7
were defined as having left ventricular hypertrophy (LVH)
[19]. The left ventricular systolic function was assessed by
the left ventricular ejection fraction (LVEF). Diastolic func-
tion was assessed by recording mitral flow with standard
pulsed Doppler technique [20], and measurements of early
diastolic peak flow velocity (E), late diastolic peak flowvelocity (A) and the ratio of early to late flow velocity peaks
(E/A ratio).
Statistical analyses
The data were analyzed using SPSS software, version 15.0
(SPSS, Chicago, IL, USA). The descriptive statistics are
presented as percentages for the discrete variables and as
the means (standard deviation) for the continuous vari-
ables. The non-parametric variables are expressed as the
median and interquartile range. The comparisons of the
continuous variables between the groups were tested by
Student’s t-test or the non-parametric test. The differences
among the categorical variables were analyzed using the
χ2 test or the two-tailed Fisher’s exact test, as appropriate.
In the univariate analyses, a linear regression model was
employed to examine the association between the sleep
quality scores (the dependent variable) and the indepen-
dent variables, including duration of CKD, diabetes (yes/
no), current smoker (yes/no), alcohol intake (yes/no),
BMI, BDI-SF score, clinic BP and clinical variables. A mul-
tiple linear regression (stepwise method) was performed
to evaluate the relationship between the sleep quality
scores and those independent variables with a potential
association (crude p < 0.15 in univariate analyses) with a
dependent variable in a univariate linear regression.
Univariate and multivariate logistic regression analyses
were used to explore the independent associations of
LVH (LVH vs. no LVH) with sleep quality scores. A uni-
variate and multiple linear regression model was also
employed to examine the association between the E/A
ratio (dependent variable) and the sleep quality scores.
All potential association variables (crude p < 0.15 in uni-
variate analyses) and BDI score were tested further in
multivariate regression analyses. All of the values are
two-tailed, and the significance is defined as p < 0.05.
Age and sex were forced to be included in the regression
models for all of the regression analyses.
Results
Sample characteristics
The mean age of the subjects was 39 ± 15 years (range
18–70 years). Median estimated glomerular filtration rate
(eGFR) was 69.4(15.8-110.9) ml/min/1.73 m2. The study
included 260 males (60.9%) and 167 females (39.1%). Of
the patients, 44 (10.3%) had diabetes; 186 patients (43.6%)
had hypertension. The average global PSQI score was
9.4 ± 2.5. A total of 332 patients (77.8%) had poor sleep
quality as defined as a PSQI score > 5.
Comparison of the clinical and laboratory data between
the poor sleep quality group and the good sleep
quality group
Compared with the good sleepers, the patients with
poor sleep quality had an increased LVMI level (47.1 ±
Table 1 Characteristics of the patients in the good sleepers group and the poor sleepers group
Characteristic Overall Good sleepers Poor sleepers P value
(n = 427) (n = 95) (n = 332)
Age (years) 39 ± 15 38 ± 13 39 ± 15 0.141
Sex ratio (M/F) 260/167 56/39 204/128 0.401
Duration of CKD (months) 5 (1–24) 6 (1–24) 5 (1–24) 0.761
Current smoker, n (%) 79 (18.5%) 20 (21.1%) 59 (17.8%) 0.457
Alcohol intake, n (%) 26 (6.1%) 7 (7.4%) 19 (5.7%) 0.626
BMI (kg/m2) 22.8 ± 3.6 22.7 ± 4.0 22.8 ± 3.7 0.784
ACEI/ARB (%) 240 (56.2) 56 (58.9) 184 (55.4) 0.560
Diabetes (%) 44 (10.3) 6 (6.3) 39 (11.7) 0.087
Proteinuria (g/24 h) 1.41 (0.46–3.82) 1.40 (0.46–4.12) 1.42 (0.46–3.76) 0.793
Hemoglobin (g/L) 118 ± 29 122 ± 25 117 ± 29 0.261
Albumin (g/L) 33.3 ± 8.9 33.0 ± 9.0 33.3 ± 8.9 0.810
Globulin( g/L) 23.5 ± 5.1 23.2 ± 5.2 23.5 ± 5.0 0.713
Serum cystatin C (mg/L) 1.5 (1.0-3.5) 1.4 (1.0-2.5) 1.4 (0.9-3.4) 0.450
Serum creatinine (μmol/L) 104 (69–355) 89 (66–214) 114 (70–423) 0.024
eGFR (ml/min/1.73 m2) 69.4 (15.8-110.9) 85.3 (32.3-121.2) 65.9 (13.2-109.6) 0.040
Cholesterol (mmol/L) 5.0 (4.0-6.8) 5.2 (4.2-6.6) 5.0 (4.0-7.1) 0.596
Triglycerides (mmol/L) 1.7 (1.1-2.6) 1.8 (1.1-2.9) 1.8 (1.1-2.7) 0.513
LDL-C (mmol/L) 3.1 (2.3-4.5) 3.2 (2.6-4.3) 3.1 (2.3-4.6) 0.426
HDL-C (mmol/L) 1.3 ± 0.5 1.2 ± 0.4 1.3 ± 0.5 0.932
Glucose (mmol/L) 4.7 (4.2-5.3) 4.6 (4.2-5.0) 4.7 (4.2-5.3) 0.391
Calcium (mg/dL) 9.2 ± 0.7 9.1 ± 0.7 9.2 ± 0.7 0.139
Phosphate (mmol/L) 1.4 ± 0.5 1.3 ± 0.4 1.4 ± 0.5 0.274
iPTH (pg/mL) 54.6 (32.1-150.2) 48.1 (32.0-83.2) 54..7 (31.1-153.0) 0.173
Serum uric acid (umol/L) 440 ± 142 441 ± 139 441 ± 143 0.967
LVEF (%) 66.9 ± 7.7 67.9 ± 6.7 66.7 ± 7.9 0.330
LVMI (g/m2.7) 46.2 ± 14.0 41.7 ± 9.5 47.1 ± 14.6 0.019
LVH (%) 158 (40.2) 18 (28.1) 140 (41.3) 0.011
E/A ratio 1.2 ± 0.4 1.3 ± 0.5 1.2 ± 0.4 0.027
CIMT (mm) 0.66 ± 0.20 0.64 ± 0.19 0.67 ± 0.20 0.443
Hypertension (%) 186 (43.6) 43 (45.3) 143 (43.1) 0.813
SBP (mmHg) 138.2 ± 22.2 137.9 ± 20.9 138.3 ± 22.5 0.921
DBP (mmHg) 84.8 ± 13.1 85.1 ± 11.0 84.7 ± 13.5 0.826
Depression (%) 176 (41.2) 12 (12.6) 164 (49.4) <0.001
BDI-SF score 3 (1–7) 1 (0–2) 4 (2–8) <0.001
PSQI score 9.4 ± 2.5 3.5 ± 1.3 10.9 ± 2.7 <0.001
CKD stage
CKD(I- II) (%) 222 55 (24.8) 167 (75.2) 0.117
CKD (III- V) (%) 205 40 (19.5) 165 (80.5)
(SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index, eGFR: estimated glomerular filtration rate; LDL-C: low-density lipoprotein cholesterol;
HDL-C: high-density lipoprotein cholesterol; iPTH: intact parathyroid hormone; SBP: systolic blood pressure; DBP: diastolic blood pressure; BDI-SF: short form of the Beck
Depression Inventory; CKD: Chronic kidney disease; CIMT: Carotid intima-media thickness; E/A ratio: Early/late diastolic peak flow velocity ratio; LVH: Left ventricular
hypertrophy; LVMI: left ventricular mass index; Serum calcium is corrected by the following formula:[calcium] (mg/dL) =measured [calcium] + ( 4.0-[serum albumin(mg/
dl)]) × 0.8, PSQI: Pittsburgh Sleep Quality Index).
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Age (years) 0.149 0.004 0.155 0.004
Duration of CKD (months) 0.104 0.054 - -
Male vs. female 0.024 0.637 - -
Current smoker (no vs. yes) −0.046 0.283
Alcohol intake (no vs. yes) −0.039 0.368
BMI (kg/m2) 0.010 0.863
Diabetes (no vs. yes) 0.086 0.116 - -
Proteinuria (g/24 h) −0.047 0.398
Hemoglobin (g/L) −0.174 0.004 - -
Albumin (g/L) 0.065 0.224
eGFR (ml/min/1.73 m2) −0.224 <0.001 - -
Cholesterol (mmol/L) −0.031 0.575
Triglyceride (mmol/L) −0.033 0.543
LDL-C (mmol/L) −0.054 0.339
Calcium (mg/dL) 0.073 0.152
Phosphate (mmol/L) 0.140 0.007 - -
iPTH (pg/mL) 0.139 0.018 - -
Serum uric acid (umol/L) 0.029 0.587
SBP (mmHg) 0.030 0.585
DBP (mmHg) 0.064 0.218
BDI-SF score 0.413 <0.001 0.427 <0.001
(aall of the variables were adjusted by age, sex. bThe age, sex, duration of CKD, diabetic vs. non diabetic status, eGFR, hemoglobin, phosphate, iPTH and BDI-score were
included in the multivariate model (stepwise method). -Without significance and not able to be included in the multivariate model. eGFR: estimated glomerular filtration
rate; iPTH: intact parathyroid hormone, SBP: systolic blood pressure; DBP: diastolic blood pressure; BDI-SF: short form of the Beck Depression Inventory).
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http://www.biomedcentral.com/1471-2369/15/13114.6 g/m2.7 vs. 41.7 ± 9.5 g/m2.7, P < 0.05), a higher pro-
portion of LVH (41.3% vs. 28.1%; p < 0.05), a lower E/A
ratio (1.2 ± 0.4 vs. 1.3 ± 0.5, P <0.05), a higher BDI score
(4 (2–8) vs. 1 (0–2); p < 0.001). The poor sleep quality
group had a higher level of serum creatinine [114
(70–423) umol/L vs. 89 (66–214) umol/L, P <0.05] and a
lower eGFR value [65.9 (13.2-109.6) ml/min/1.73 m2
VS. 85.3 (32.3-121.2) ml/min/1.73 m2, P <0.05]. The
two subgroups were similar for the other variables. The
results are shown in Table 1.Figure 1 Comparison of the PSQI score between the Non-LVH
group and the LVH group. * means P < 0.001.Independent characteristics of patients with poor
sleep quality
Table 2 demonstrates the strengths of the associations bet-
ween sleep quality and the clinical and laboratory charac-
teristics. The univariate linear regression analysis revealed
that older age, a longer duration of CKD, lower eGFR,
lower hemoglobin level, higher BDI scores, higher serum
levels of phosphate and iPTH were significantly associated
with poor sleep quality. We found that only older age andhigher BDI scores were independently associated with
poor sleep quality in the multivariate regression analysis.
Association of sleep quality with LVH
Figure 1 shows that the LVH patients had higher
PSQI scores when compared with the non-LVH group
(P < 0.001). Table 3 shows the associations of LVH and
Table 3 Univariate and multivariate logistic regression analysis for left ventricular hypertrophy (1 = no LVH; 2 = LVH)
OR(95% CI) Crude Adjusted Adjusted
P valuea OR(95% CI) P valueb
Age (per 1 year) 1.061 (1.040-1.082) <0.001 - -
Duration of CKD (per 1 month) 0.999 (0.993-1.005) 0.759 - -
Male vs. female 1.525 (0.879-2.645) 0.133 - -
Current smoker (no vs. yes) 0.931 (0.476-1.822) 0.835
Alcohol intake (no vs. yes) 1.980 (0.780-5.027) 0.151
BMI (per 1 kg/m2) 0.992 (0.908-1.083) 0.855
Diabetes (no vs. yes) 1.203 (0.614-2.989) 0.690
ACEI/ARB (no/yes) 0.768 (0.431-1.368) 0.370
Proteinuria (per 1 g/24 h) 0.939 (0.815-1.081) 0.381
Hemoglobin (per 1 g/L) 0.971 (0.960-0.983) <0.001 - -
ALB (per 1 g/L) 1.017 (0.977-1.061) 0.421
eGFR < 60 ml/min/1.73 m2 8.150 (3.234-20.542) <0.001 3.943 (1.255-12.387) 0.019
Cholesterol (per 1 mmol/L) 0.940 (0.844-1.048) 0.264
Triglyceride (per 1 mmol/L) 0.930 (0.711-1.217) 0.598
LDL-C (per 1 mmol/L) 0.936 (0.816-1.047) 0.347
Calcium (per 1 mg/dL) 0.397 (0.223-0.646) <0.001 - -
Phosphate (per 1 mg/dL) 2.998 (1.500-5.992) 0.002 - -
iPTH (per 1 pg/mL) 1.006 (1.003-1.010) <0.001 1.004 (1.002-1.007) 0.001
Serum uric acid (per 1 umol/L) 1.003 (1.001-1.006) 0.004 - -
PSQI score 1.117 (1.041-1.200) 0.002 1.092 (1.011-1.179) 0.025
BDI-SF score 1.061 (0.012 - 1.111) 0.014 - -
SBP (per 1 mmHg) 1.044 (1.028-1.061) <0.001 1.034 (1.015-1.054) <0.001
DBP (per 1 mmHg) 1.056 (1.032-1.081) <0.001 - -
(aall of the variables were adjusted by age, sex. bThe age, sex, hemoglobin, eGFR, phosphate, serum calcium, Serum uric acid, iPTH, SBP, DBP, BDI -score and PSQI score
were included in the multivariate model (backward method). -Without significance and not able to be included in the multivariate model. eGFR: the estimated
glomerular filtration rate; iPTH: intact parathyroid hormone, SBP: systolic blood pressure; DBP: diastolic blood pressure; PSQI: Pittsburgh Sleep Quality Index).
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hemoglobin, serum calcium, phosphate and iPTH; Serum
uric acid; eGFR < 60 ml/min/1.73 m2; SBP and DBP; and
poor sleep quality were significantly associated with LVH
when adjusted only for age and gender. In the multivariate
regression analysis, an eGFR < 60 ml/min/1.73 m2, a
higher serum iPTH level, higher SBP and poor sleep qua-
lity were independently associated with LVH.
Association of sleep quality with the E/A ratio
Figure 2 shows that the PSQI score was significantly as-
sociated with the E/A ratio (r = 0.190, p < 0.001) and was
not associated with the CIMT (r = −0.021, p = 0.724). As
shown in Table 4, the linear regression analyses revealed
that age, the serum phosphate, BMI, Serum uric acid, SBP,
DBP and PSQI scores were negatively associated with the
E/A ratio, whereas the eGFR was positively associated
with the E/A ratio when adjusted only with age and gen-
der. We found that age, the DBP, BMI and PSQI scoreswere independent factors associated with the E/A ratio in
the further multivariate regression analysis.
Discussion
Few studies have addressed sleep quality in subjects with
CKD prior to ESRD. Our study first investigated sleep
quality in Chinese CKD patients prior to dialysis and
found that the prevalence of poor sleep quality was as
high as 77.8%. Previous studies have shown that the
prevalence of sleep disorders based on questionnaires
have provided widely different estimates of in-patients
with CKD, which ranged from 14–85% in CKD patients
[3], 41–83% in HD patients [21-23] and 49–85% in PD
patients [7,21,24]. These rates might vary be because of
the different life styles, genetic factors, environmental
conditions and primary cause of CKD in the study popu-
lations or because different questionnaires were used to
estimate sleep quality in the studies. Our study shows
that a higher sleep quality score was positively associated
Figure 2 Correlation analysis between the PSQI score and the E/A ratios (a) and CIMT(b).
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duration of CKD and inversely associated with the
hemoglobin level and the eGFR in the univariate analyses.
After adjusting for the confounding factors, only higher
BDI scores and older age were independently associated
with sleep quality. Numerous factors could potentially
contribute to the high prevalence of sleep problems in
CKD patients including older age, pain, depression, dys-
pnea, nausea and pruritus; however, it appears that there
is no association between sleep quality and specific labora-
tory variables such as hemoglobin, albumin, calcium or
phosphorus in CKD patients [4,25]. As in most of the
studies [4,9,26], our study failed to show a relationship be-
tween renal function and sleep quality in the multivariate
linear regression analysis, suggested that poor sleep quality
could exist at a very early stage in CKD and that the de-
creased renal function and other specific laboratory vari-
ables might not be the direct cause of poor sleep in CKD
patients. A series of associated comorbidities and symp-
toms such as high depression scores, pain, nausea and
itchiness could be aggravated by declining renal function
and affect the sleep quality in CKD patients [4]. In re-
search with a small sample size (n = 58), Kurella et al. [8]
reported a significant association between eGFR and sleep
quality among non-African-American subjects.
Previous studies have shown that poor sleep quality is
an important risk factor for the development of cardio-
vascular diseases [5] in the general population. The PSQI
score was reported to be positively associated with cardio-
vascular disease in CAPD patients [7]. Recent research
indicated that an increase in observed/predicted LVM is
independently associated with adverse cardiovascular out-
comes in patients with stages 3–5 CKD [27]. Diastolic
dysfunction is a strong predictor of mortality in patients
with CKD [28]. From the univariate and multivariate re-
gression analysis, our study first showed that higher PSQI
scores were associated with LVH and lower E/A ratios.The mechanisms of these associations are unclear. One of
the explanations might be that poor sleep quality is asso-
ciated with blunting of the nocturnal dip in blood pressure
and with higher activation of the sympathetic nervous
system [29]; the sympathetic nervous system and non-
dipping blood pressure are risk factors of LVH and lower
E/A ratios [30,31]. Reduced sleep quality might decrease
the normal nocturnal increase in the plasma renin activity
and aldosterone levels [3] and might lead to LVH. Our
findings might facilitate a better understanding of the
pathogenesis and consequences of cardiovascular diseases
in CKD patients with poor sleep quality.
The strength of our study was that we were the first to
report the prevalence and risk factors of poor sleep quality
in Chinese pre-dialysis CKD patients; we first reported
that poor sleep quality is closely related with cardiovascu-
lar damage. Several limitations should be considered when
interpreting our findings. First, the subjective reporting of
sleep quality by use of the PSQI might lead to reporting
bias. It has been shown that patients with sleep problems
are more likely to overestimate their sleep difficulties [32].
In addition, the PSQI measures overall general sleep qua-
lity rather than a specific form of sleep disorder. Future
studies with objective measures are warranted, but using a
polysomnogram or other objective measure is costly in a
large clinical study such as this study. Second, the nature
of the cross-sectional design in this study did not allow us
to determine a causal relationship between poor sleep
quality and cardiovascular damage and pre-dialysis pa-
tients. Cardiovascular damage might lead to poor sleep
quality [33,34]. Further multi-center follow-up studies
with larger samples are necessary to determine the effect
of factors of such as poor sleep quality and to investigate
the complex nature of the relationship between sleep
quality and cardiovascular damage in Chinese CKD pa-
tients. In addition, although our study excluded sleep
apnea and chronic obstructive pulmonary disease and find
Table 4 Univariate and multivariate Linear Regression
model for the predictors of the E/A ratios
P valuea Coefficient β P valueb
Age (years) −0.650 <0.001 −0.613 <0.001
Duration of CKD (months) −0.059 0.186
Male vs. female −0.032 0.459 - -
Current smoker (no vs. yes) −0.054 0.318
Alcohol intake (no vs. yes) −0.024 0.585
BMI (kg/m2) −0.139 0.002 −0.113 0.029
ACEI/ARB (no/yes) 0.041 0.369
Diabetes (no vs. yes) −0.060 0.192
Proteinuria (g/24 h) −0.005 0.907
Hemoglobin (g/L) 0.008 0.870
Albumin (g/L) −0.031 0.485
eGFR (ml/min/1.73 m2) 0.126 0.012 - -
Cholesterol (mmol/L) −0.048 0.286
Triglyceride (mmol/L) −0.060 0.168
LDL-C (mmol/L) −0.053 0.247
Calcium (mg/dL) −0.064 0.138 - -
Phosphate (mmol/L) −0.096 0.025 - -
iPTH (pg/mL) −0.068 0.140 - -
Serum uric acid (umol/L) −0.168 <0.001 - -
PSQI scores −0.129 0.007 −0.115 0.028
BDI-SF score −0.065 0.229 - -
SBP (mmHg) −0.173 <0.001 - -
DBP (mmHg) −0.191 <0.001 −0.184 <0.001
(aall of the variables were adjusted by age, sex. bthe age, sex, BMI, eGFR,
serum calcium, phosphate and iPTH, Serum uric acid, SBP, DBP, BDI score and
PSQI scores were included in the multivariate model (stepwise method).
-Without significance and not able to be included in the multivariate model
and hence these independent variables were not included into the model to
predict dependent variable. DBP: diastolic blood pressure; eGFR: estimated
glomerular filtration rate; iPTH: intact parathyroid hormone, SBP: systolic blood
pressure; PSQI: Pittsburgh Sleep Quality Index).
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http://www.biomedcentral.com/1471-2369/15/131that depression can affect sleep quality, other factors, such
as pruritis, chronic pain and caffeine use might affect
sleep, were not include in this study. These may also con-
found the results. Finally, the studied population in this
study was relatively young. These findings in the current
study might not be able to generalize to older population.Conclusions
This study demonstrates a high prevalence of poor sleep
quality in pre-dialysis CKD patients. Poor sleep quality is
an independent risk factor for LVH and ventricular dia-
stolic function in pre-dialysis CKD patients. Assessment
with the PSQI is the first step in detecting sleep disorders
and should be used in all renal patients to determine for
whom more accurate procedures are needed to identify
and treat specific disorders. Treatment to improve sleepquality might improve the overall quality of life and posi-
tively affect CVD.
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